India — Fishery/Seafood Products — Squid-Octopus

← back to leaderboard

India received 1 FDA import refusal in Squid-Octopus, part of Fishery/Seafood Products between 2020-Q3 and 2023-Q2. Volume is newly active in the last year. The most-cited issues are salmonella and filthy. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 1 were hazard refusals and 0 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2020-Q3 2020-Q3: 0 0 2020-Q4 2020-Q4: 0 0 2021-Q1 2021-Q1: 0 0 2021-Q2 2021-Q2: 0 0 2021-Q3 2021-Q3: 0 0 2021-Q4 2021-Q4: 0 0 2022-Q1 2022-Q1: 0 0 2022-Q2 2022-Q2: 0 0 2022-Q3 2022-Q3: 0 0 2022-Q4 2022-Q4: 0 0 2023-Q1 2023-Q1: 0 1 2023-Q2 2023-Q2: 1

Recent rejections